chr20-7982592-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021156.4(TMX4):āc.709A>Gā(p.Arg237Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021156.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMX4 | NM_021156.4 | c.709A>G | p.Arg237Gly | missense_variant | 8/8 | ENST00000246024.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMX4 | ENST00000246024.7 | c.709A>G | p.Arg237Gly | missense_variant | 8/8 | 1 | NM_021156.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000283 AC: 7AN: 247592Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134036
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460816Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726792
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.709A>G (p.R237G) alteration is located in exon 8 (coding exon 8) of the TMX4 gene. This alteration results from a A to G substitution at nucleotide position 709, causing the arginine (R) at amino acid position 237 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at